Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-24

FDA Approved: CLOBAZAM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved an original ANDA for CLOBAZAM (clobazam) by Aurobindo Pharma Limited. It is a generic treatment for seizures associated with Lennox-Gastaut syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

ORIG AP for CLOBAZAM (CLOBAZAM)